Working… Menu

Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03221166
Recruitment Status : Terminated (Difficulty in recruiting subjects who meet the inclusion/exclusion criteria)
First Posted : July 18, 2017
Last Update Posted : September 4, 2020
Centro di Riferimento Oncologico - Aviano
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Information provided by (Responsible Party):
IRCCS Burlo Garofolo

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 31, 2020
Actual Study Completion Date : July 31, 2020